Pharmacologically directed design of leukemia therapy.
Pharmacologically directed design of leukemia therapy.
复制标题
白血病治疗的药理学指导设计。
DOI:
10.1007/978-3-642-74643-7_111
复制
发表时间:
1990
期刊:
影响因子:
--
通讯作者:
Keating,M
中科院分区:
文献类型:
--
作者:
Plunkett,W;Heinemann,V;Estey,E;Keating,M
Most nucleoside analogues require intracellular metabolism, usually to the 5’-triphosphate, to produce cytotoxicity. This reflects one mechanism of action of these drugs: inhibition of DNA synthesis through effects on enzymes whose natural substrates are nucleotides. Strong correlations have been demonstrated between cytotoxity in experimental systems and the cellular pharmacology and pharmacodynamics of nucleotides of nucleoside antimetabolites [1, 2]. Recently, analytical procedures used in experimental studies, principally high-pressure liquid chromatography, have been adapted for investigations of nucleoside analogue metabolites in human leukemia cells during therapy [3].These studies were supported by grant CA32839 from the National Cancer Institute, Department of Health and Human Services.
登录
查看更多内容
DOI:
10.1016/0002-9343(86)90287-1
发表时间:
1986
期刊:
The American journal of medicine
影响因子:
--
作者:
Kantarjian,HM;Estey,EH;Plunkett,W;Keating,MJ;Walters,RS;Iacoboni,S;McCredie,KB;Freireich,EJ
通讯作者:
Freireich,EJ
DOI:
--
发表时间:
1985
期刊:
影响因子:
--
作者:
J. Liliemark;W. Plunkett;D. Dixon
通讯作者:
D. Dixon
DOI:
10.1111/j.1600-0609.1986.tb01590.x
发表时间:
1986
期刊:
Scandinavian journal of haematology. Supplementum
影响因子:
--
作者:
Plunkett,W;Iacoboni,S;Keating,MJ
通讯作者:
Keating,MJ
影响因子:
4
作者:
Plunkett,W;Liliemark,JO;Estey,E;Keating,MJ
通讯作者:
Keating,MJ
影响因子:
11.2
作者:
Shewach,DS;Plunkett,W
通讯作者:
Plunkett,W